Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) traded down 16% during mid-day trading on Friday . The company traded as low as $4.20 and last traded at $4.20. 1,483 shares traded hands during trading, a decline of 84% from the average session volume of 9,053 shares. The stock had previously closed at $5.00.
Peak Pharmaceuticals Stock Performance
The business has a 50 day simple moving average of $1.92 and a 200-day simple moving average of $1.86.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Read More
- Five stocks we like better than Peak Pharmaceuticals
- Dividend Payout Ratio Calculator
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- The Most Important Warren Buffett Stock for Investors: His Own
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
